Humana Inc. (NYSE:HUM) Shares Sold by Transcend Capital Advisors LLC

Transcend Capital Advisors LLC lessened its holdings in Humana Inc. (NYSE:HUM - Free Report) by 63.5% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 1,330 shares of the insurance provider's stock after selling 2,313 shares during the period. Transcend Capital Advisors LLC's holdings in Humana were worth $352,000 as of its most recent SEC filing.

A number of other institutional investors have also recently added to or reduced their stakes in HUM. Revolve Wealth Partners LLC acquired a new position in shares of Humana during the fourth quarter worth about $202,000. Oppenheimer & Co. Inc. lifted its position in Humana by 17.2% during the 4th quarter. Oppenheimer & Co. Inc. now owns 3,313 shares of the insurance provider's stock worth $841,000 after acquiring an additional 486 shares in the last quarter. Proficio Capital Partners LLC purchased a new position in Humana in the 4th quarter worth approximately $14,097,000. US Bancorp DE grew its position in Humana by 0.5% in the fourth quarter. US Bancorp DE now owns 28,459 shares of the insurance provider's stock valued at $7,220,000 after acquiring an additional 144 shares in the last quarter. Finally, Metis Global Partners LLC grew its position in Humana by 4.7% in the fourth quarter. Metis Global Partners LLC now owns 5,237 shares of the insurance provider's stock valued at $1,329,000 after acquiring an additional 235 shares in the last quarter. 92.38% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of research firms have recently commented on HUM. Wall Street Zen raised shares of Humana from a "hold" rating to a "buy" rating in a research report on Friday. Guggenheim started coverage on shares of Humana in a report on Wednesday, April 9th. They issued a "buy" rating and a $326.00 price objective on the stock. Bank of America lowered their target price on Humana from $320.00 to $260.00 and set a "neutral" rating for the company in a research note on Tuesday, June 17th. Cantor Fitzgerald reissued a "neutral" rating and issued a $290.00 price target on shares of Humana in a report on Thursday, May 1st. Finally, Mizuho lifted their price objective on Humana from $305.00 to $316.00 and gave the stock an "outperform" rating in a report on Wednesday, April 9th. Sixteen equities research analysts have rated the stock with a hold rating and eight have issued a buy rating to the company's stock. Based on data from MarketBeat, the company has a consensus rating of "Hold" and an average price target of $280.76.

Humana Price Performance

Shares of NYSE:HUM opened at $241.82 on Monday. The company has a market cap of $29.18 billion, a PE ratio of 17.10, a P/E/G ratio of 1.82 and a beta of 0.43. Humana Inc. has a fifty-two week low of $212.45 and a fifty-two week high of $406.46. The firm has a 50-day simple moving average of $241.94 and a 200 day simple moving average of $259.20. The company has a quick ratio of 1.91, a current ratio of 1.91 and a debt-to-equity ratio of 0.71.

Humana (NYSE:HUM - Get Free Report) last posted its earnings results on Wednesday, April 30th. The insurance provider reported $11.58 EPS for the quarter, beating the consensus estimate of $10.07 by $1.51. The company had revenue of $32.11 billion during the quarter, compared to analyst estimates of $32 billion. Humana had a return on equity of 14.47% and a net margin of 1.42%. The business's revenue was up 8.4% compared to the same quarter last year. During the same period in the prior year, the company earned $7.23 earnings per share. On average, sell-side analysts anticipate that Humana Inc. will post 16.47 EPS for the current year.

Humana Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, July 25th. Stockholders of record on Friday, June 27th will be issued a dividend of $0.885 per share. This represents a $3.54 annualized dividend and a dividend yield of 1.46%. The ex-dividend date is Friday, June 27th. Humana's dividend payout ratio (DPR) is 25.04%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.